Dynamic analysis of peritoneal dialysis associated peritonitis

ASAIO Journal

Volumn 50, Issue 6, 2004, Pages 568-576

  Hotchkiss, John R ^a,b   Hermsen, Elizabeth D ^c   Hovde, Laurie B ^c   Simonson, Dana A ^c   Rotschafer, John C ^c   Crooke, Philip S ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORBIDITY; PERITONEAL DIALYSIS;

BACTERIA; BIOFILMS; ENZYME KINETICS;

DIALYSIS;

ARTICLE; BACTERIAL GROWTH; BACTERIAL KINETICS; BIOFILM; CONTROLLED STUDY; CORRELATION ANALYSIS; DIALYSATE; DISEASE ASSOCIATION; LIQUID; MATHEMATICAL COMPUTING; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; PERITONEAL DIALYSIS; PERITONITIS; PHASE TRANSITION; PREDICTION; STATISTICAL SIGNIFICANCE;

BACTERIA; BACTERIAL INFECTIONS; DIALYSIS SOLUTIONS; HUMANS; KINETICS; MODELS, THEORETICAL; PERITONEAL DIALYSIS; PERITONITIS; PLANKTON;

EID: 10044223329     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MAT.0000145238.98158.F0     Document Type: Article

References (47)

1. Finkelstein E, Jekel J, Troidel L, et al: Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. Am J Kidney Dis 39: 1278-1286, 2002.
2. Zelenitsky S, Barns L, Findlay I, et al: Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 36: 1009-1013, 2000.
3. Golper T, Hartstein A: Analysis of the causative pathogens in uncomplicated CAPD-associated peritonitis: Duration of therapy, relapses, and prognosis. Am J Kidney Dis 7: 141-145, 1986.
4. Ota K, Mineshima M, Watanabe N, Naganuma S: Functional deterioration of the peritoneum: Does it occur in the absence of peritonitis? Nephrol Dial Transplant 2: 30-33, 1987.
5. Selgas R, Fernandez-Reyes MJ, Bosque E, et al: Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. Am J Kidney Dis 23: 64-73, 1994.
6. Davies SJ, Bryan J, Phillips L, Russell GI: Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 11: 498-506, 1996.
7. West TE, Walshe JJ, Krol CP, Amsterdam D: Staphylococcal peritonitis in patients on continuous peritoneal dialysis. J Clin Microbiol 23: 809-812, 1986.
8. Holley JL, Bernardini J, Johnston JR, Piraino B: Methicillin-resistant staphylococcal infections in an outpatient peritoneal dialysis program. Am J Kidney Dis 16: 142-146, 1990.
9. Pérez-Fontán M, Rosales M, Rodríguez-Carmona A, García Falcón T, et al: Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 39: 337-341, 2002.
10. Sieradzki K, Roberts RB, Serur D, Margrave J, et al: Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy. J Clin Microbiol 37: 39-44, 1999.
11. Tokors JI, Frank M, Alter M, Arduino M: National surveillance of dialysis-associated diseases in the United States, 2000. Available at www.cdc.gov/ncidod/hip/Dialysis/dialysis.htm.
12. Tokars J: Infections due to antimicrobial-resistant pathogens in the dialysis unit. Blood Purif 18: 355-360, 2000.
13. Tokars JI, Gehr T, Jarvis WR, et al: Vancomycin-resistant enterococci colonization in patients at seven hemodialysis centers. Kidney Int 60: 1511-1516, 2001.
14. D'Agata EM, Green WK, Schulman G, et al: Vancomycin-resistant enterococci among chronic hemodialysis patients: A prospective study of acquisition. Clin Infect Dis 32: 23-29, 2001.
15. Atta MG, Eustace JA, Song X, et al: Outpatient vancomycin use and vancomycin-resistant enterococcal colonization in maintenance dialysis patients. Kidney Int 59: 718-24, 2001.
16. Wong S, Ho PL, Woo P, Yuen K: Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin Infect Dis 29: 760-767, 1999.
17. Glancey GR, Cameron JS, Ogg CS: Peritoneal drainage: An important element in host defense against staphylococcal peritonitis in patients on CAPD. Nephrol Dial Transplant 7: 627-631, 1992.
18. Macdonald WA, Watts J, Bowmer MI: Factors affecting Staphylococcus epidermidis growth in peritoneal dialysis solutions. J Clinical Microbiology 24: 104-107, 1986.
19. Watson SP, Clements MO, Foster SJ: Characterization of the starvation-survival response of Staphylococcus aureus. J Bacteriol 180: 1750-1758, 1998.
20. Clements MO, Foster SJ. Starvation recovery of Staphylococcus aureus 8325-4. Microbiology 144: 1755-1763, 1998.
21. Zelenitsky S, Franczuk C, Fine A, et al: Antibiotic tolerance of peritoneal bacterial isolates in dialysis fluids. J Antimicrob Chemother 49: 863-866, 2002.
22. Wilcox MH, Geary I, Spencer RC: In-vitro activity of imipenem, in comparison with cefuroxime and ciprofloxacin, against coagulase-negative staphylococci in broth and peritoneal dialysis fluid. J Antimicrob Chemother 29: 49-55, 1992.
23. Craddock CF, Edwards R, Finch RG: Pseudomonas peritonitis in continuous ambulatory peritoneal dialysis: Laboratory predictors of treatment failure. J Hosp Infect 10: 179-186, 1987.
24. Shalit I, Welch DF, San Joaquin VH, Marks MI: In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid. Antimicrob Agents Chemother 27: 908-911, 1985.
25. Ludlam H, Johnston L, Hopkins P: Susceptibility testing of bacteria recovered from patients with peritonitis complicating continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 36: 1097-1101, 1992.
26. Rubin J, Humphries J, Smith G, Bower J: Antibiotic activity in peritoneal dialysate. Am J Kidney Dis 3: 205-208, 1983.
27. Duwe AK, Vas SI, Weatherhead JW: Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro. Infect Immun 33: 130-135, 1981.
28. Dobos CJ, Bohler J, Zhou XJ, Andre M, et al: Persistent inhibition of neutrophil function by glucose based dialysis solutions. ASAIO J 40: M435-439, 1994.
29. Peterson P, Lee D, Suh H, et al: Intracellular survival of Candida albicans in peritoneal macrophages from chronic peritoneal dialysis patients. Am J Kidney Dis 7: 146-152, 1986.
30. Tsai TJ, Yen CJ, Fang CC, et al: Effect of intraperitoneally administered agents on human peritoneal mesothelial cell growth. Nephron 71: 23-28, 1995.
31. Gorman SP, Adair CC, Mawhinney WM: Incidence and nature of peritoneal catheter biofilm determined by electron and confocal laser scanning microscopy. Epidemiol Infect 112: 551-559, 1994.
32. Marrie T, Noble M, Costerton JW: Examination of the morphology of bacteria adhering to peritoneal dialysis catheters by scanning and transmission electron microscopy. J Clin Microbiolog 18: 1388-1398, 1983.
33. Dasgupta M, Ward K, Noble P, et al: Development of bacterial biofilms on silastic catheter materials in peritoneal dialysis fluid. Am J Kidney Dis 23: 709-716, 1994.
34. Gorman SP, Mawhinney WM, Adair CC, et al: Confocal laser scanning microscopy of peritoneal catheter surfaces. J Med Microbiol 38: 411-417, 1993.
35. Costerton JW, Stewart P, Creenberg EP: Bacterial biofilms: A common cause of persistent infections. Science 284: 1318-1322, 1999.
36. Donlan R, Costerton JW: Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193, 2002.
37. Dunne WM Jr.: Bacterial adhesion: Seen any good biofilms lately? Clin Microbiol Rev 15: 155-166, 2002.
38. Ward KH, Olson ME, Lam K, Costerton JW: Mechanism of persistent infection associated with peritoneal implants. J Med Microbiol 36: 406-413, 1992.
39. Khaled CH, Finkelstein FO, Carey HB, et al: Method for studying development of colonization and infection of dialysis catheters. Adv Perit Dial 17: 163-171, 2001.
40. Dasgupta M, Lam K, Ulan R, et al: An extracorporeal model of biofilm-adherent bacterial microcolony colonization for the study of peritonitis in continuous ambulatory peritoneal dialysis. Am J Nephrology 8: 118-122, 1988.
41. Lamba NMK, Baumgartner JN, Cooper SL: The influence of thrombus components in mediating bacterial adhesions to biomaterials. J Biomater Sci Polymer Edn 11: 1227-1237, 2000.
42. Brant JA, Hanlon CW, Denyer SP: Development of an in-vitro model to study the growth characteristics of Staphylococcus epidermidis in continuous ambulatory peritoneal dialysis. J Pharm Pharmacol 50: 1195-203, 1998.
43. de Fijter CW, Oe LP, Nauta JJ, et al: Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med 120: 264-271, 1994.
44. Huang JW, Hung KY, Yen CJ, Wu KD, Tsai TJ: Comparison of infectious complications in peritoneal dialysis patients using either a twin-bag system or automated peritoneal dialysis. Nephrol Dial Transplant 16: 604-607, 2001.
45. Woodrow C, Turney JH, Cook JA, et al: Nocturnal intermittent peritoneal dialysis. Nephrol Dial Transplant 9: 399-403, 1994.
46. Basile C, De Padova F: Comparison of peritonitis incidence in CAPD and automated peritoneal dialysis. Nephrol Dial Transplant 16: 1957-1958, 2001.
47. Gahrmani N, Gorban-Brennan N, Kliger AS, Finkelstein FO: Infection rates in end-stage renal disease patients treated with CCPD and CAPD using the UltraBag system. Adv Perit Dial 11: 164-167, 1995.